Low cardiac 123I-MIBG uptake in late-onset familial amyloid polyneuropathy type I (TTR Met30)

[1]  G. Sobue,et al.  Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. , 1999, Brain : a journal of neurology.

[2]  C. Lücking,et al.  Cardiac uptake of [123I]MIBG separates Parkinson’s disease from multiple system atrophy , 1999, Neurology.

[3]  P. Merlet,et al.  Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability , 1999, European Journal of Nuclear Medicine.

[4]  K. Ito,et al.  A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. , 1995, Journal of the autonomic nervous system.

[5]  Yoshiya Tanaka,et al.  Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type I , 1995, The Lancet.

[6]  Y. Koike,et al.  A radiological analysis of heart sympathetic functions with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. , 1994, Journal of the autonomic nervous system.

[7]  B. Lucchesi,et al.  Scintigraphic detection of regional disruption of adrenergic neurons in the heart. , 1988, American heart journal.

[8]  N. Ito,et al.  Hereditary generalized amyloidosis with polyneuropathy. Clinicopathological study of 65 Japanese patients. , 1987, Brain : a journal of neurology.

[9]  W. Beierwaltes,et al.  Radiolabeled Adrenergic Neuron-Blocking Agents: Adrenomedullary Imaging with [131I] Iodobenzylguanidine , 1980 .

[10]  Y. Ando,et al.  Early involvement of motor nerve dysfunction in atypical cases with familial amyloidotic polyneuropathy (FAP) type I. , 1993, Muscle & nerve.